Pfizer/BioNtech
Latest
Pfizer/BioNTech say 3 COVID shots generate good response in under-5s
May 23 (Reuters) - Drugmakers Pfizer Inc PFE.N and BioNTech said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under the age…
Pfizer’s COVID-19 shot causes mostly mild side effects in young kids – U.S. CDC
Pfizer Inc and BioNTech SE's COVID-19 vaccine caused mostly mild side effects in children aged 5 to 11 years, according to data…
Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations
Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the…
FACTBOX-COVID-19 vaccine rollout for children aged 5-11 in the EU
The European Union rollout of the Pfizer and BioNTech COVID-19 vaccine for 5- to 11-year-olds should begin Dec. 13, as countries are…
Two-dose vaccines induce lower antibodies against Omicron, study finds
Dec 13 (Reuters) - Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found,…
UPDATED: EU launch of Pfizer/BioNTech COVID shot for younger children brought forward to Dec 13
he European Union-wide rollout of Pfizer and BioNTech's COVID-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week…
Vaccine combinations with different technologies may be best
Healthcare workers in France who got a first shot of AstraZeneca’s COVID-19 vaccine and then the Pfizer/BioNTech vaccine for their second shot…
FDA says benefits outweigh risks for Pfizer/BioNTech COVID-19 vaccine in children
Scientists at the U.S. Food and Drug Administration (FDA) said on Friday that the likely benefits of giving the Pfizer/BioNTech COVID-19 vaccine…
Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids
Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds,…
UPDATED: EU reviewing cases of rare body inflammation after COVID-19 shots
Europe's medicines regulator said on Friday it was reviewing if there was a risk of a rare inflammatory condition after inoculation with…

